Plasma Heat Shock Protein 90 Alpha: A Valuable Predictor of Early Chemotherapy Effectiveness in Advanced Non-Small-Cell Lung Cancer

BACKGROUND Heat shock protein-90 alpha (HSP90a) is more abundant in non-small-cell lung cancer (NSCLC) patients than in control individuals. However, whether it can reflect chemotherapy efficacy remains unknown. This study aimed to investigate the association of HSP90a with chemotherapy in advanced...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Medical science monitor 2021-01, Vol.27, p.e924778-e924778
Hauptverfasser:	Zhong, Bo, Shen, Juxin, Zhang, Chunyi, Zhou, Guozhong, Yu, Yuefang, Qin, E, Tang, Jixian, Wu, Dongping, Liang, Xiaochao
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Biomarkers, Tumor - blood Carcinoma, Non-Small-Cell Lung - blood Carcinoma, Non-Small-Cell Lung - drug therapy Carcinoma, Non-Small-Cell Lung - pathology Clinical Research Female HSP90 Heat-Shock Proteins - blood Humans Lung Neoplasms - blood Lung Neoplasms - drug therapy Lung Neoplasms - pathology Male Middle Aged Response Evaluation Criteria in Solid Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!